10 results on '"Cencini E"'
Search Results
2. MARGINAL ZONE LYMPHOMA INTERNATIONAL PROGNOSTIC INDEX (MZL‐IPI): A PROGNOSTIC SCORE FOR THE ENTIRE SPECTRUM OF MARGINAL ZONE LYMPHOMAS. A FIL AND SPORE‐MER STUDY.
3. P1256: A NOVEL DROP‐OFF DIGITAL PCR ASSAY FOR CXCR4 MUTATION SCREENING IN IGM GAMMOPATHIES: FIRST DATA FROM THE FONDAZIONE ITALIANA LINFOMI BIO‐WM STUDY.
4. DIRECT-ACTING ANTIVIRALS DURING OR AFTER IMMUNO-CHEMOTHERAPY IN HEPATITIS C VIRUS-ASSOCIATED DIFFUSE LARGE B-CELL LYMPHOMAS.
5. PROGNOSTIC IMPACT OF TUMOR‐ASSOCIATED MACROPHAGES, LYMPHOCYTE‐TO‐MONOCYTE AND NEUTROPHIL‐TO‐LYMPHOCYTE RATIO IN NEWLY DIAGNOSED DIFFUSE LARGE B‐CELL LYMPHOMA PATIENTS.
6. PROGNOSTIC IMPACT OF TUMOR‐ASSOCIATED MACROPHAGES, LYMPHOCYTE‐TO‐MONOCYTE AND NEUTROPHIL‐TO‐LYMPHOCYTE RATIO IN NEWLY DIAGNOSED DIFFUSE LARGE B‐CELL LYMPHOMA PATIENTS.
7. Is bendamustine plus rituximab a suitable option for rituximab-refractory duodenal-type follicular lymphoma?
8. Radiotherapy plus rituximab as first-line regimen for localized follicular lymphoma.
9. Role of genetic polymorphisms on R-CHOP efficacy in diffuse large B-cell lymphoma patients: An interim analysis of a multicenter prospective pharmacogenetic study.
10. GENE POLYMORPHISMS AS PREDICTORS OF TREATMENT EFFICACY AND TOXICITY IN PATIENTS WITH INDOLENT NON-HODGKIN LYMPHOMAS RECEIVING BENDAMUSTINE AND RITUXIMAB.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.